18 May 2013
Keywords: phase, iii, trial, loteprednol, pharmos, corporation, israel
Article | 07 March 1994
Pharmos Corporation of Israel has announced that it has successfully completed the first of four pivotal Phase III trials of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.